TRIMETHOBENZAMIDE Drug Patent Profile

Which patents cover Trimethobenzamide, and when can generic versions of Trimethobenzamide launch?

Trimethobenzamide is a drug marketed by Heritage Pharma Avet, Lupin, Sun Pharm Industries, Am Regent, Bpi Labs, Hospira, Smith And Nephew, Solopak, and Watson Labs. and is included in twelve NDAs.

The generic ingredient in TRIMETHOBENZAMIDE is trimethobenzamide hydrochloride. There are six drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the trimethobenzamide hydrochloride profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Trimethobenzamide

A generic version of TRIMETHOBENZAMIDE was approved as trimethobenzamide hydrochloride by LUPIN on August 20^th, 2003.

Summary for TRIMETHOBENZAMIDE

US Patents:	0
Applicants:	9
NDAs:	12
Drug Prices:	Drug price information for TRIMETHOBENZAMIDE
DailyMed Link:	TRIMETHOBENZAMIDE at DailyMed

See drug prices for TRIMETHOBENZAMIDE

US Patents and Regulatory Information for TRIMETHOBENZAMIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Heritage Pharma Avet	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	CAPSULE;ORAL	205950-001	Nov 21, 2023	AB	RX	No	Yes
Smith And Nephew	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	088960-001	Apr 4, 1986		DISCN	No	No
Am Regent	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	091330-001	Mar 8, 2011		DISCN	No	No
Am Regent	TRIMETHOBENZAMIDE HYDROCHLORIDE PRESERVATIVE FREE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	091329-001	Mar 8, 2011		DISCN	No	No
Smith And Nephew	TRIMETHOBENZAMIDE HYDROCHLORIDE	trimethobenzamide hydrochloride	INJECTABLE;INJECTION	089043-001	Apr 4, 1986		DISCN	No	No